Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Annu Rev Public Health. 2010;31:105-20. doi: 10.1146/annurev.publhealth.121208.131051.

    Prevention trials: their place in how we understand the value of prevention strategies.

    Source

    Department of Surgery, Washington University School of Medicine, Saint Louis, Missouri 63110, USA. colditzg@wustl.edu

    Abstract

    Several key factors bear on the interpretation of prevention trials and observational studies that inform prevention strategies. These factors include the underlying disease process and aspects of the intervention: sustainability of behavior change, the time course of the intervention within the disease process, dose and duration of exposure needed to effect risk reduction, durability of the impact of intervention, and methodological problems in implementing and interpreting randomized trials and observational studies to evaluate prevention strategies. The question asked through an intent-to-treat analysis of a randomized controlled trial (RCT) differs from that in the observational setting. Furthermore, the long duration necessary to conduct prevention trials and the resulting lack of adherence to therapy can bias results toward the null. A broader range of approaches to evaluate prevention interventions and programs with improved knowledge synthesis and translation to public health practice will speed our progress toward achieving public health and prevention of chronic diseases.

    PMID:
    20070190
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3618690
    Free PMC Article

      Supplemental Content

      Icon for Atypon Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk